Participants will be able to:

• Evaluate current therapies for AD, their side effects, and their benefits for daily living of the patient.
• Describe new methods of diagnosing AD by using imaging and biomarkers.
• Discuss various pharmacological interventions designed to attenuate disease progression.
• State safety monitoring needed for pharmacological interventions.
• Evaluate failures and errors in the attempts to develop new treatments for AD.
• Discuss latest results of clinical trials of new drugs and treatments.